Our annual survey of the best NBTAcademicStartups in 2021 continues with chromamedicine and tunetx_news, two companies using epigenome editing for precision medicine
Since the 1990s, attempts to manipulate the epigenome to fight diseases like cancer have relied on DNA-modifying drugs such as azacitidine. These drugs act more like therapeutic sledgehammers than precision medicines.
Now, with decades of research on DNA-binding domains and a burgeoning number of enzymatic effectors that can write or erase epigenetic marks, precision epigenome editing is coming into view. These advances have not been lost on investors, who in 2021 poured $165 million into two epigenome-editing companies: Tune Therapeutics and Chroma Medicine. Earlier this year, a third firm, Epic Bio, spun out of Stanford University, with a $55 million A round.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Baker Hughes will reorganize, shuffle executives as it continues transition to energy tech companyThe company said it will streamline business segments from four down to two, creating an...
Les mer »
Firefighters rescue fallen horse near Snoqualmie RidgeIt took fire crews over two hours to rescue Stevie the horse.
Les mer »
Experimental brain implant zaps patients, quells food cravings, helps with binge eatingAccording to a report from the scientific journal Nature Medicine, two California women who were diagnosed with a binge-eating disorder, underwent surgery after several treatments failed to mend their cravings.
Les mer »
Twitter starts testing an edit button, but you have to pay for itTwitter Blue subscribers will get the edit button first.
Les mer »